CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
SpeediCathdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03337048
NCT03337048N/ACompleted

Exploratory Study Investigating Urodynamic Parameters During Catheterisation

Coloplast A/S·interventional·Posted Nov 8, 2017·Updated Aug 12, 2024

In Brief

A clinical study evaluating SpeediCath for Spinal Cord Injuries and Enlarged Prostate With Lower Urinary Tract Symptoms. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The objective of the study is to explore and understand how urodynamic parameters are affected when emptying the bladder with an intermittent catheter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 8, 2017
Enrollment StartNov 30, 2017
Primary CompletionMay 29, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.7 years ago

Interventions

SpeediCathdevice

SpeediCath is a standard intermittent catheter that is on the market.